|
|
Volumn 17, Issue 1, 2011, Pages 18-19
|
|
The Role of Cytotoxic Therapy with Hematopoietic Stem Cell Transplantation in the Treatment of Diffuse Large B Cell Lymphoma: Update of the 2001 Evidence-Based Review
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION;
AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION;
CANCER PATIENT;
CLINICAL EVALUATION;
CYTOTOXICITY;
DIFFUSE LARGE B CELL LYMPHOMA;
EVIDENCE BASED PRACTICE;
HUMAN;
MEDICAL RESEARCH;
METHODOLOGY;
MYELOABLATIVE CONDITIONING;
NOTE;
REDUCED INTENSITY CONDITIONING;
STUDY DESIGN;
EVIDENCE BASED MEDICINE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
LARGE CELL LYMPHOMA;
MULTIMODALITY CANCER THERAPY;
REVIEW;
CYTOTOXIN;
COMBINED MODALITY THERAPY;
CYTOTOXINS;
EVIDENCE-BASED MEDICINE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
LYMPHOMA, LARGE B-CELL, DIFFUSE;
|
|
EID: 79956213880
PISSN: 10838791
EISSN: 15236536
Source Type: Journal
DOI: 10.1016/j.bbmt.2010.11.001 Document Type: Note |
|
Times cited : (16)
|
|
References (0)
|